Literature DB >> 31620687

Not Otherwise Specified-Type Sarcoma of Breast with CD10 Expression: Case Report.

Bermal Hasbay1, Filiz Aka Bolat1, Hülya Aslan2, Hüseyin Özgür Aytaç3.   

Abstract

Primary breast sarcomas are very rare and account less than 1% of invasive breast carcinomas. Primary sarcomas of breast are leiomyosarcoma, angiosarcoma, liposarcoma, fibrosarcoma, rhabdomyosarcoma, malignant peripheral nerve sheath tumor and pleomorphic sarcoma. Recently, a new CD10 positive group of sarcoma was identified. These tumors cannot be classified as a soft tissue sarcoma and show diffuse strong positive staining pattern with CD10 (NSCD10). Herein we report clinical and morphological characteristics of two cases diagnosed with not otherwise specified-type sarcoma with CD10 expression by histologically and immunohistochemical findings with the literature. NSCD10 shows similarity with leiomyosarcoma and sarcomatoid-type metaplastic carcinoma histomorphologically among specific sarcomas of breast. CD10 expression should be taken into consideration in the presence of not diagnosed and not specified tumors and CD10 should be added to the immunohistochemical panel.
Copyright © 2019 Turkish Federation of Breast Diseases Associations.

Entities:  

Keywords:  Breast; CD10 positive sarcoma; sarcoma

Year:  2019        PMID: 31620687      PMCID: PMC6776127          DOI: 10.5152/ejbh.2019.4295

Source DB:  PubMed          Journal:  Eur J Breast Health


  8 in total

1.  The CD10 enzyme is a key player to identify and regulate human mammary stem cells.

Authors:  Elodie Bachelard-Cascales; Marion Chapellier; Emmanuel Delay; Gaetan Pochon; Thibault Voeltzel; Alain Puisieux; Claude Caron de Fromentel; Véronique Maguer-Satta
Journal:  Stem Cells       Date:  2010-06       Impact factor: 6.277

2.  Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma.

Authors:  P Chu; D A Arber
Journal:  Am J Clin Pathol       Date:  2000-03       Impact factor: 2.493

3.  CD10, actin, and vimentin expression in breast phyllodes tumors correlates with tumor grades of the WHO grading system.

Authors:  Wen-Chiuan Tsai; Jong-Shiao Jin; Jyh-Cherng Yu; Lai-Fa Sheu
Journal:  Int J Surg Pathol       Date:  2006-04       Impact factor: 1.271

4.  Mammary NOS-type sarcoma with CD10 expression: a rare entity with features of myoepithelial differentiation.

Authors:  Sebastian Leibl; Farid Moinfar
Journal:  Am J Surg Pathol       Date:  2006-04       Impact factor: 6.394

5.  Primary nonphylloides breast sarcomas.

Authors:  D Kay Blanchard; Carol A Reynolds; Clive S Grant; John H Donohue
Journal:  Am J Surg       Date:  2003-10       Impact factor: 2.565

6.  Is mammary not otherwise specified-type sarcoma with CD10 expression a distinct entity? A rare case report with immunohistochemical and ultrastructural study.

Authors:  Guang-Zhi Yang; Jing Li; Hua Jin; Hua-Ye Ding
Journal:  Diagn Pathol       Date:  2013-01-28       Impact factor: 2.644

Review 7.  Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literature.

Authors:  C Adem; C Reynolds; J N Ingle; A G Nascimento
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

8.  CD10 Positive Recurrent Undifferentiated Mammary Sarcoma in a Young Female: A Rare Case Report with Brief Review of Literature.

Authors:  Kachnar Varma; Pooja Gupta; Payel Das; Pallavi Singh; Vatsala Misra
Journal:  Rare Tumors       Date:  2015-06-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.